Implantable sustained release device and a method of use therefor in the treatment of brain disorders
OwnerAdnan I. Qureshiinventor
Life of this patent
Estimating the term…
Abstract
A biocompatible and bioresorbable implantable device that is intended to be deployed in the middle meningeal artery through intra-arterial catheters and release an anesthetic agent for a prolonged period into the branches of the middle meningeal artery to treat severe headaches including migraine and trigeminal neuralgias. The implantable device may be a mesh with multiple helical loops, fenestrated collapsible hollow shell or spheroid, or folded sheath.
Claims18
A method of treatment of recurrent headaches and/or trigeminal neuralgia, the method comprising the steps of:
- providing a sustained release device that is configured to be implanted in a blood vessel supplying the dura mater in the brain,
- wherein the sustained release device comprises an anesthetic agent, the sustained release device configured for sustained release of the anesthetic agent in the blood vessel for a prolonged period.
A method of treatment of recurrent headaches and trigeminal neuralgia, the method comprising the steps of:
- implanting a device in a middle meningeal artery for sustained release of an anesthetic agent for a prolonged period.
Dependencies are inferred from the claim text.